TNFR2 blockade alone or in combination with PD‐1 blockade shows therapeutic efficacy in murine cancer models
Author:
Affiliation:
1. Immunobiology Laboratory Massachusetts General Hospital and Harvard Medical School Boston Massachusetts USA
2. Biostatistics Center Massachusetts General Hospital Boston Massachusetts USA
Publisher
Wiley
Subject
Cell Biology,Immunology,Immunology and Allergy
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/JLB.5MA0420-375RRRRR
Reference27 articles.
1. Immune checkpoint-targeted therapy: cancer and autoimmune diseases represent two sides of the same coin
2. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
3. PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
4. Immune checkpoint inhibitors: recent progress and potential biomarkers
5. Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreatic Cancer;Cancer Discovery;2023-03-22
2. TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments;Frontiers in Immunology;2023-02-14
3. The Immunosuppressive Effect of TNFR2 Expression in the Colorectal Cancer Microenvironment;Biomedicines;2023-01-10
4. TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4+Foxp3+ regulatory T cells;Cellular Oncology;2022-11-12
5. TNFR2 antagonist and agonist: a potential therapeutics in cancer immunotherapy;Medical Oncology;2022-09-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3